LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

PRICE T ROWE ASSOCIATES INC /MD/'s Holding History (CIK: 0000080255)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 6,478,836 Value ($000) $3 Avg Close — Range —
Q4 2024
Shares 6,910,749 Value ($000) $4 Avg Close — Range —
Q3 2024
Shares 7,352,277 Value ($000) $10 Avg Close — Range —
Q2 2024
Shares 7,872,369 Value ($000) $11 Avg Close — Range —
Q1 2024
Shares 6,731,477 Value ($000) $15 Avg Close — Range —
Q4 2023
Shares 6,638,883 Value ($000) $13 Avg Close — Range —
Q3 2023
Shares 6,686,197 Value ($000) $10 Avg Close — Range —
Q2 2023
Shares 8,161,094 Value ($000) $26 Avg Close — Range —
Q1 2023
Shares 3,967,338 Value ($000) $9 Avg Close — Range —
Q4 2022
Shares 3,675,686 Value ($000) $13 Avg Close — Range —
Q3 2022
Shares 5,306,607 Value ($000) $38,898 Avg Close — Range —
Q2 2022
Shares 5,327,496 Value ($000) $34,735 Avg Close — Range —
Q1 2022
Shares 5,493,922 Value ($000) $27,744 Avg Close — Range —
Q4 2021
Shares 5,141,291 Value ($000) $39,794 Avg Close — Range —
Q3 2021
Shares 3,659,270 Value ($000) $54,157 Avg Close — Range —
Q2 2021
Shares 2,500,000 Value ($000) $40,600 Avg Close — Range —